Heinz Dürk
- Pathology and Forensic Medicine top 0.5%
- Oncology top 2%
- Genetics top 1%
- Pulmonary and Respiratory Medicine top 10%
- Neurology top 5%
- Co-authors
- Mathias RummelUlrich von GrünhagenDorothea Kofahl-KrauseDieter HoelzerWolfram BruggerGerhard HeilUlrich KaiserMartina Stauch
- Topics
- Lymphoma Diagnosis and Treatment (6 papers)Lung Cancer Treatments and Mutations (5 papers)Multiple Myeloma Research and Treatments (4 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Heinz Dürk
28 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Pathology and Forensic Medicine 1.3k
- Oncology 991
- Genetics 767
- Pulmonary and Respiratory Medicine 275
- Neurology 213
Countries citing papers authored by Heinz Dürk
This map shows the geographic impact of Heinz Dürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Dürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Dürk more than expected).
Fields of papers citing papers by Heinz Dürk
This network shows the impact of papers produced by Heinz Dürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Dürk. The network helps show where Heinz Dürk may publish in the future.
Co-authorship network of co-authors of Heinz Dürk
This figure shows the co-authorship network connecting the top 25 collaborators of Heinz Dürk. A scholar is included among the top collaborators of Heinz Dürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz Dürk. Heinz Dürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trialbreakdown → | 962 |
| 4 | 31 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 18 | |
| 10 | 332 | |
| 11 | 71 | |
| 12 | 7 | |
| 13 | 16 | |
| 14 | 27 | |
| 15 | 2 | |
| 16 | 17 | |
| 17 | [Cryoglobulinemia in chronic hepatitis C. Improvement by alpha-interferon is independent of virus elimination]. | 2 |
| 18 | Behçet's disease: epidemiology and eye manifestations in German and Mediterranian patients. | 21 |
| 19 | 10 | |
| 20 | 3 |
About Heinz Dürk
Heinz Dürk is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pharmacology, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Genetics (767 citations), Pathology and Forensic Medicine (1.3k citations) and Oncology (991 citations). Heinz Dürk has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Mathias Rummel, Ulrich von Grünhagen, Dorothea Kofahl-Krause, Dieter Hoelzer, Wolfram Brugger, Gerhard Heil, Ulrich Kaiser, Martina Stauch, Christina Balser and Juergen Barth. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.